Volume 53, Issue 2, Pages (August 2010)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Volume 60, Issue 1, Pages (January 2014)
Volume 62, Issue 6, Pages (June 2015)
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
Volume 32, Issue 2, Pages (February 2000)
Volume 41, Issue 6, Pages (December 2004)
Volume 67, Issue 3, Pages (September 2017)
Volume 50, Issue 4, Pages (April 2009)
Hepatic CD141+IFNλ+ DC subset: One against all?
Volume 68, Issue 5, Pages (May 2018)
Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar 
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Volume 44, Issue 4, Pages (April 2006)
NS5A inhibitors in the treatment of hepatitis C
Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis.
Immigration and viral hepatitis
Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis  Astrid Marot, Jean Henrion, Jean-François.
Virological tools to diagnose and monitor hepatitis C virus infection
Omalizumab treatment downregulates dendritic cell FcεRI expression
K. L. Nash, M. E. Allison, D. McKeon, D. J. Lomas, C. S. Haworth, D
A Sustained Viral Response Is Associated With Reduced Liver-Related Morbidity and Mortality in Patients With Hepatitis C Virus  Amit G. Singal, Michael.
Supersonic Shear Imaging and Transient Elastography With the XL Probe Accurately Detect Fibrosis in Overweight or Obese Patients With Chronic Liver Disease 
David G. Bowen, Christopher M. Walker  Journal of Hepatology 
Volume 41, Issue 3, Pages (September 2004)
Volume 69, Issue 2, Pages (August 2018)
Volume 44, Pages S19-S24 (January 2006)
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection  Anaïs Vallet-Pichard,
Volume 41, Issue 3, Pages (September 2004)
F. Li, P. Zhou, W. Deng, J. Wang, R. Mao, Y. Zhang, J. Li, J. Yu, F
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
Hepatitis C core protein – The “core” of immune deception?
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Volume 153, Issue 5, Pages e2 (November 2017)
Liposomal amphotericin B twice weekly as antifungal prophylaxis in paediatric haematological malignancy patients  K. Bochennek, L. Tramsen, N. Schedler,
Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel 
From non-A, non-B hepatitis to hepatitis C virus cure
Volume 134, Issue 7, Pages e2 (June 2008)
Aloysious D. Aravinthan, Graeme J.M. Alexander  Journal of Hepatology 
Volume 61, Issue 1, Pages S69-S78 (November 2014)
‘Easy to treat’ genotypes were not created equal: Can rapid virological response (RVR) level the playing field?  Andres Duarte-Rojo, Elizabeth Jenny Heathcote,
Ming-Ling Chang, Yun-Fan Liaw  Journal of Hepatology 
Volume 141, Issue 4, Pages e3 (October 2011)
Genomic risk of hepatitis C-related hepatocellular carcinoma
Darius Moradpour, Arash Grakoui, Michael P. Manns 
The allele 4 of neck region liver-lymph node-specific ICAM-3-grabbing integrin variant is associated with spontaneous clearance of hepatitis C virus and.
Autophagy in the liver Journal of Hepatology
Volume 65, Issue 6, Pages (December 2016)
Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore 
Volume 61, Issue 1, Pages S45-S57 (November 2014)
Volume 134, Issue 7, Pages e2 (June 2008)
Volume 128, Issue 1, Pages (January 2005)
Volume 50, Issue 4, Pages (April 2009)
Prevalence and Treatment of Hepatitis C Virus Genotypes 4, 5, and 6
Volume 70, Issue 1, Pages (January 2019)
Volume 50, Issue 3, Pages (March 2009)
Immigration and viral hepatitis
Volume 63, Issue 1, Pages (July 2015)
Serum HBV pgRNA as a clinical marker for cccDNA activity
Close monitoring of serum HBV DNA levels and liver enzymes levels is most useful in the management of patients with occult HBV infection  Isabelle Chemin,
Volume 51, Issue 2, Pages (August 2009)
Hepatitis C infection: A multi-faceted systemic disease with clinical, patient reported and economic consequences  Zobair M. Younossi, Aybike Birerdinc,
Chronic hepatitis B in children and adolescents
Volume 58, Issue 5, Pages (May 2013)
New trials and results in systemic treatment of HCC
Reply to: “Flow cytometry makes all the difference”
Pathogenesis of cholestatic hepatitis C
Clinical Gastroenterology and Hepatology
Volume 62, Issue 5, Pages (May 2015)
Reversion of disease manifestations after HCV eradication
Presentation transcript:

Volume 53, Issue 2, Pages 252-260 (August 2010) CD4+ T-lymphocyte telomere length is related to fibrosis stage, clinical outcome and treatment response in chronic hepatitis C virus infection  Matthew Hoare, William T.H. Gelson, Abhi Das, Jean M. Fletcher, Susan E. Davies, Martin D. Curran, Sarah L. Vowler, Mala K. Maini, Arne N. Akbar, Graeme J.M. Alexander  Journal of Hepatology  Volume 53, Issue 2, Pages 252-260 (August 2010) DOI: 10.1016/j.jhep.2010.03.005 Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Telomere length of CD8+ and CD4+ T-cells from healthy controls and HCV-infected subjects. (A) Example of flow-FISH plots and gating strategy for analysis of telomere length. Left: Live lymphocyte gate by light-scatter characteristics. Centre: Identification of CD4+CD45RO+ cells. Right: Histograms of CD4+CD45RO+ lymphocyte telomere length from a subject with mild (filled histogram) and a subject with severe (unfilled histogram) fibrosis related to HCV infection. (B) The correlation between age and telomere length in circulating CD8+CD45RO+ lymphocytes from 41 healthy controls and (C) 135 HCV-infected subjects. (D) Telomere length of CD8+CD45RO+ lymphocytes in 41 healthy controls, 73 viraemic patients with mild fibrosis, and 61 viraemic patients with severe fibrosis. Horizontal bar represents the median. (E) Telomere length of CD4+CD45RO+ lymphocytes in 41 healthy controls, 73 viraemic patients with mild fibrosis, and 62 viraemic patients with severe fibrosis. Analysis by Kruskal–Wallis with Dunn’s multiple comparison test; bars show p<0.05. Journal of Hepatology 2010 53, 252-260DOI: (10.1016/j.jhep.2010.03.005) Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Correlation of telomere length of (A and C) CD8+CD45RO+ or (B and D) CD4+CD45RO+ lymphocytes from 133 viraemic HCV subjects with (A and B) fibrosis stage or (C and D) portal tract inflammation grade. Symbols and bars represent median and inter-quartile range; correlation by Spearman’s Rank. Journal of Hepatology 2010 53, 252-260DOI: (10.1016/j.jhep.2010.03.005) Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Fig. 3 Correlation of telomere length of (A) CD8+CD45RO+ or (B) CD4+CD45RO+ lymphocytes from 133 viraemic HCV patients with measures of the severity of liver disease: left panels, serum bilirubin (μM/L), middle panels, prothrombin time (seconds), and right panels, serum alanine transaminase (ALT) (IU/L). Journal of Hepatology 2010 53, 252-260DOI: (10.1016/j.jhep.2010.03.005) Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Fig. 4 Clinical outcome of viraemic subjects (n=124) (A and B) or viraemic patients with severe fibrosis only (n=55) (C and D) divided into subjects with telomeres longer (dashed line) or shorter (solid line) than the median. Kaplan–Meier analysis from study entry to outcome or censor date by log rank test: (A and C) CD8+CD45RO+ telomere length and (B and D) CD4+CD45RO+ telomere length. CD4+CD45RO+ telomere length from subjects with severe fibrosis (n=55) analysed with each outcome independently: (E) Development of HCC; (F) Episode of decompensation. Journal of Hepatology 2010 53, 252-260DOI: (10.1016/j.jhep.2010.03.005) Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Fig. 5 Baseline T-lymphocyte telomere length in (A) CD8+CD45RO+ and (B) CD4+CD45RO+ subsets in relation to SVR (n=85) following peg-IFNα and RBV. Analysis by Mann–Whitney U test. Journal of Hepatology 2010 53, 252-260DOI: (10.1016/j.jhep.2010.03.005) Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Supplementary Fig. 1 Baseline T-lymphocyte telomere length in (A and C) CD8+CD45RO+ and (B and D) CD4+CD45RO+ subsets in relation to HCV viral load (A and B) or viral genotype (C and D) (n=85). Analysis by Spearman’s Rank correlation and Kruskal–Wallis test. Journal of Hepatology 2010 53, 252-260DOI: (10.1016/j.jhep.2010.03.005) Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Supplementary Fig. 2 Correlation between CD4+CD45RO+ and CD8+CD45RO+ baseline T-lymphocyte telomere length in viraemic HCV patients (n=133). Slope and 95% CI, goodness of fit by r2. Journal of Hepatology 2010 53, 252-260DOI: (10.1016/j.jhep.2010.03.005) Copyright © 2010 European Association for the Study of the Liver Terms and Conditions